Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!

>

MEETINGS / EVENTS

RSS

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter

Summary:

FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur

Summary:

FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled

Summary:

Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

President Signs “Food and Drug Administration Safety and Innovation Act” Into Law; Includes Key ASA-Advanced Drug Shortage Provisions

Tuesday, July 10, 2012

On July 9, President Barack Obama signed into law S. 3187, the "Food and Drug Administration Safety Act" law, which contains important provisions to address drug shortages. Previously the legislation cleared the U.S. Senate by a vote of 92-4 and the U.S. House by a voice vote.

This law represents a major step forward in efforts to address drug shortages. Specifically, at the urging of ASA and other drug shortages stakeholders, lawmakers used this bill as a vehicle to address the national drug shortages issue and this law includes an entire title consisting of provisions intended to help prevent and mitigate drug shortages.

ASA President Jerry A. Cohen, M.D. offered the following remarks:

"We are pleased to report the successful passage and signing of the Food and Drug Administration Safety Act. ASA's consistent leadership and advocacy alongside other key stakeholders proved fruitful in advancing the key drug shortages provisions of this act."

Review the legislation as passed by the House of Representatives and the Senate.
Review a summary of the legislation.
Review ASA’s letter to the Senate and House negotiators.
Learn more about ASA’s work to address drug shortages.

« Back to Washington Alerts